Cooper ME - Search Results

1

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.

Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM. Thallas-Bonke V, et al. Among authors: cooper me. Diabetes. 2008 Feb;57(2):460-9. doi: 10.2337/db07-1119. Epub 2007 Oct 24. Diabetes. 2008. PMID: 17959934

2

Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.

Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G. Soulis-Liparota T, et al. Diabetes. 1991 Oct;40(10):1328-34. doi: 10.2337/diab.40.10.1328. Diabetes. 1991. PMID: 1834497

3

Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.

Kelly DJ, Gilbert RE, Cox AJ, Soulis T, Jerums G, Cooper ME. Kelly DJ, et al. Among authors: cooper me. J Am Soc Nephrol. 2001 Oct;12(10):2098-2107. doi: 10.1681/ASN.V12102098. J Am Soc Nephrol. 2001. PMID: 11562408

4

A low-sodium diet potentiates the effects of losartan in type 2 diabetes.

Houlihan CA, Allen TJ, Baxter AL, Panangiotopoulos S, Casley DJ, Cooper ME, Jerums G. Houlihan CA, et al. Among authors: cooper me. Diabetes Care. 2002 Apr;25(4):663-71. doi: 10.2337/diacare.25.4.663. Diabetes Care. 2002. PMID: 11919122 Clinical Trial.

5

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria.

Forbes JM, Bonnet F, Russo LM, Burns WC, Cao Z, Candido R, Kawachi H, Allen TJ, Cooper ME, Jerums G, Osicka TM. Forbes JM, et al. Among authors: cooper me. J Hypertens. 2002 May;20(5):985-92. doi: 10.1097/00004872-200205000-00034. J Hypertens. 2002. PMID: 12011660

6

Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction.

Houlihan CA, Akdeniz A, Tsalamandris C, Cooper ME, Jerums G, Gilbert RE. Houlihan CA, et al. Among authors: cooper me. Diabetes Care. 2002 Jun;25(6):1072-7. doi: 10.2337/diacare.25.6.1072. Diabetes Care. 2002. PMID: 12032117 Clinical Trial.

7

Role of nephrin in renal disease including diabetic nephropathy.

Cooper ME, Mundel P, Boner G. Cooper ME, et al. Semin Nephrol. 2002 Sep;22(5):393-8. doi: 10.1053/snep.2002.34724. Semin Nephrol. 2002. PMID: 12224046 Review.

8

Advanced glycation end products and diabetic complications.

Stitt AW, Jenkins AJ, Cooper ME. Stitt AW, et al. Among authors: cooper me. Expert Opin Investig Drugs. 2002 Sep;11(9):1205-23. doi: 10.1517/13543784.11.9.1205. Expert Opin Investig Drugs. 2002. PMID: 12225243 Review.

9

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.

Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LM, Jerums G, Osicka TM. Forbes JM, et al. Among authors: cooper me. Diabetes. 2002 Nov;51(11):3274-82. doi: 10.2337/diabetes.51.11.3274. Diabetes. 2002. PMID: 12401719

10

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

Wilkinson-Berka JL, Kelly DJ, Koerner SM, Jaworski K, Davis B, Thallas V, Cooper ME. Wilkinson-Berka JL, et al. Among authors: cooper me. Diabetes. 2002 Nov;51(11):3283-9. doi: 10.2337/diabetes.51.11.3283. Diabetes. 2002. PMID: 12401720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

716 results

Search Page

Filters